The University of Southampton
University of Southampton Institutional Repository

Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model

Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model
Inflammatory processes have been implicated in the pathogenesis of brain damage after stroke. In rodent stroke models, focal ischemia induces several proinflammatory chemokines, including monocyte chemoattractant protein-1 (MCP-1). The individual contribution to ischemic tissue damage, however, is largely unknown. To address this question, the authors subjected MCP-1-deficient mice (MCP-1-/-) to permanent middle cerebral artery occlusion (MCAO). Measurement of basal blood pressure, cerebral blood flow, and blood volume revealed no differences between wild-type (wt) and MCP-1-/- mice. MCAO led to similar cerebral perfusion deficits in wt and MCP-1-/- mice, excluding differences in the MCA supply territory and collaterals. However, compared with wt mice, the mean infarct volume was 29% smaller in MCP-1-/- mice 24 hours after MCAO (P = 0.022). Immunostaining showed a reduction of phagocytic macrophage accumulation within infarcts and the infarct border in MCP-1-/- mice 2 weeks after MCAO. At the same time point, the authors found an attenuation of astrocytic hypertrophy in the infarct border and thalamus in MCP-1-/- mice. However, these effects on macrophages and astrocytes in MCP-1-/- mice occurred too late to suggest a protective role in acute infarct growth. Of note: at 6 hours after MCAO, MCP-1-/- mice produced significantly less interleukin-1beta in ischemic tissue; this might be related to tissue protection. The results of this study indicate that inhibition of MCP-1 signaling could be a new acute treatment approach to limit infarct size after stroke.
MCP-1, chemokines, cytokines, neuroinflammation, focal cerebral ischemia, astrocytes, microglia
0271-678X
308-317
Hughes, Paula M.
eb8721bf-bb7f-467b-a9e9-729a7ddcd2e3
Allegrini, Peter R.
4aa513d8-a525-4980-a9d3-67c40b219fe5
Rudin, Markus
d7498c0e-3262-48c8-829e-abbd76bbe127
Perry, V. Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
Mir, Anis K.
b01159e3-9191-442a-a633-a2ae73de9492
Wiessner, Christoph
e07aad3d-8f0f-4d46-b5c7-6e7be836b176
Hughes, Paula M.
eb8721bf-bb7f-467b-a9e9-729a7ddcd2e3
Allegrini, Peter R.
4aa513d8-a525-4980-a9d3-67c40b219fe5
Rudin, Markus
d7498c0e-3262-48c8-829e-abbd76bbe127
Perry, V. Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
Mir, Anis K.
b01159e3-9191-442a-a633-a2ae73de9492
Wiessner, Christoph
e07aad3d-8f0f-4d46-b5c7-6e7be836b176

Hughes, Paula M., Allegrini, Peter R., Rudin, Markus, Perry, V. Hugh, Mir, Anis K. and Wiessner, Christoph (2002) Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. Journal of Cerebral Blood Flow & Metabolism, 22 (3), 308-317. (doi:10.1097/00004647-200203000-00008).

Record type: Article

Abstract

Inflammatory processes have been implicated in the pathogenesis of brain damage after stroke. In rodent stroke models, focal ischemia induces several proinflammatory chemokines, including monocyte chemoattractant protein-1 (MCP-1). The individual contribution to ischemic tissue damage, however, is largely unknown. To address this question, the authors subjected MCP-1-deficient mice (MCP-1-/-) to permanent middle cerebral artery occlusion (MCAO). Measurement of basal blood pressure, cerebral blood flow, and blood volume revealed no differences between wild-type (wt) and MCP-1-/- mice. MCAO led to similar cerebral perfusion deficits in wt and MCP-1-/- mice, excluding differences in the MCA supply territory and collaterals. However, compared with wt mice, the mean infarct volume was 29% smaller in MCP-1-/- mice 24 hours after MCAO (P = 0.022). Immunostaining showed a reduction of phagocytic macrophage accumulation within infarcts and the infarct border in MCP-1-/- mice 2 weeks after MCAO. At the same time point, the authors found an attenuation of astrocytic hypertrophy in the infarct border and thalamus in MCP-1-/- mice. However, these effects on macrophages and astrocytes in MCP-1-/- mice occurred too late to suggest a protective role in acute infarct growth. Of note: at 6 hours after MCAO, MCP-1-/- mice produced significantly less interleukin-1beta in ischemic tissue; this might be related to tissue protection. The results of this study indicate that inhibition of MCP-1 signaling could be a new acute treatment approach to limit infarct size after stroke.

This record has no associated files available for download.

More information

Published date: March 2002
Keywords: MCP-1, chemokines, cytokines, neuroinflammation, focal cerebral ischemia, astrocytes, microglia

Identifiers

Local EPrints ID: 56503
URI: http://eprints.soton.ac.uk/id/eprint/56503
ISSN: 0271-678X
PURE UUID: d112935e-517a-45aa-a403-6d63d6ab628a

Catalogue record

Date deposited: 07 Aug 2008
Last modified: 15 Mar 2024 11:02

Export record

Altmetrics

Contributors

Author: Paula M. Hughes
Author: Peter R. Allegrini
Author: Markus Rudin
Author: V. Hugh Perry
Author: Anis K. Mir
Author: Christoph Wiessner

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×